Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
1 clinical trials · Condition
◉ Watch Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer (NCT03776487) | M.D. Anderson Cancer Center | 2019-01-07 |
Track Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.